Novel Mechanisms in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Cardiopulmonary Remodeling In Nondiabetic Patients with Systolic Heart Failure Using Sodium-Glucose Cotransporter 2 Inhibitors: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.Current cardiology reviews · 2026
   Pooled it
2. Diagnostic and prognostic value of serum C-reactive protein in heart failure with preserved ejection fraction: a systematic review and meta-analysis.Heart failure reviews · 2021
   Pooled it
3. Comorbidity-Driven Inflammation in HFpEF: Immune Profiling and Therapeutic Targets.Current heart failure reports · 2026
   Review
4. Heart Failure: Epidemiology, Pathophysiology, and Management.MedComm · 2026
   Review
5. Edoxaban Safety and Effectiveness in Real-Life Patients with Heart Failure and Atrial Fibrillation: EMAYIC Study.Journal of clinical medicine · 2025
   Article
6. Development and Validation of R-hf Risk Score in Acute Heart Failure Patients in the Middle East.Oman medical journal · 2023
   Article
7. P-wave durations from automated electrocardiogram analysis to predict atrial fibrillation and mortality in heart failure.ESC heart failure · 2023
   Article
8. Efficacy of guideline-directed medical treatment in heart failure with mildly reduced ejection fraction.ESC heart failure · 2023
   Article
9. Reverse Atrial Remodeling in Heart Failure With Recovered Ejection Fraction.Journal of the American Heart Association · 2023
   Article
10. Electrocardiogram-based artificial intelligence for the diagnosis of heart failure: a systematic review and meta-analysis.Journal of geriatric cardiology : JGC · 2022
    Article
11. Triglyceride-glucose index and the risk of heart failure: Evidence from two large cohorts and a mendelian randomization analysis.Cardiovascular diabetology · 2022
    Article
12. β-blocker and 1-year outcomes among patients hospitalized for heart failure with mid-range ejection fraction.European heart journal. Cardiovascular pharmacotherapy · 2022
    Article
13. Editorial: Risk Stratification Strategies for Cardiac Rhythm Abnormalities.Frontiers in cardiovascular medicine · 2022
    Article
14. Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction.ESC heart failure · 2021
    Article
15. Derivation of an electronic frailty index for predicting short-term mortality in heart failure: a machine learning approach.ESC heart failure · 2021
    Observational
16. Predictive value of HESC heart failure · 2021
    Article
17. Evaluation of the prescribing practice of guideline-directed medical therapy among ambulatory chronic heart failure patients.BMC cardiovascular disorders · 2021
    Observational
18. The Value of IGF-1 and IGFBP-1 in Patients With Heart Failure With Reduced, Mid-range, and Preserved Ejection Fraction.Frontiers in cardiovascular medicine · 2021
    Article
19. Predictive Value of HFA-PEFF Score in Patients With Heart Failure With Preserved Ejection Fraction.Frontiers in cardiovascular medicine · 2021
    Article
20. Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis.Frontiers in cardiovascular medicine · 2021
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as